Myasthenia Gravis - 34 Studies Found
Completed |
: Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis : Myasthenia Gravis : 2006-03-21 : Drug: Intravenous ImmuneGlobulin |
Recruiting |
: Exercise for Stable Myasthenia Gravis : Myasthenia Gravis : 2010-01-12 : Other: Exercise 3 month exercise intervention, three days |
Active, not recruiting |
: Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis : Myasthenia Gravis : 2009-09-29 : Drug: Prednisone - Azathioprine Rapid strategy consists of |
Recruiting |
: Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis : Myasthenia Gravis : 2014-01-13 : Behavioral: Physical exercise programme using a rowing machine 3 sessions per week of individualized phy |
Completed |
: Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy : Myasthenia Gravis : 2006-02-21 :
|
Completed |
: A Pilot Trial of Rituxan in Refractory Myasthenia Gravis : Refractory Myasthenia Gravis : 2008-01-14 : Drug: Rituximab (Rituxan) Four weekly IV infusions of Rituxan with dosage individually calculated per su |
Active, not recruiting |
: Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis : Myasthenia Gravis : 2015-11-13 :
|
Terminated |
: Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis : Myasthenia Gravis : 2011-11-01 : Drug: Subcutaneous immunoglobulins Immunoglobulins used subcutaneously for maintenance of other immune m |
Recruiting |
: Trial of Orencia in Patients With Myasthenia Gravis : Myasthenia Gravis : 2017-02-17 : Drug: Abatacept Injection Subcutaneous administration of abatacept |
Recruiting |
: Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis : Myasthenia Gravis : 2014-03-27 : Drug: HIZENTRA ® Other Name: Immune Globulin Subcutaneous (Human), 20% Liquid |